Patent details
EP3651734 Title: COMPOSITIONS COMPRISING AN RNA POLYMERASE INHIBITOR AND CYCLODEXTRIN FOR TREATING VIRAL INFECTIONS
Basic Information
- Publication number:
- EP3651734
- PCT Application Number:
- US2018041482
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP187464979
- PCT Publication Number:
- WO2019014247
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- COMPOSITIONS COMPRISING AN RNA POLYMERASE INHIBITOR AND CYCLODEXTRIN FOR TREATING VIRAL INFECTIONS
- French Title of Invention:
- COMPOSITION COMPRENANT UN INHIBITEUR DE RNA POLYMERASE ET DE LA CYCLODEXTRINE POUR TRAITER DES INFECTIONS VIRALES
- German Title of Invention:
- ZUSAMMENSETZUNGEN MIT EINEM RNA-POLYMERASEHEMMER UND CYCLODEXTRIN ZUR BEHANDLUNG VON VIRUSINFEKTIONEN
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 13/12/2024
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 23/12/2024
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 13/11/2024
- Unitary Effect Registration Date:
- 23/12/2024
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 10/07/2018
- Grant date:
- 13/11/2024
- EP Publication Date:
- 20/05/2020
- PCT Publication Date:
- 17/01/2019
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 13/11/2024
- EP B1 Publication Date:
- 13/11/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 10/07/2038
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 06/11/2024
- Name:
- Gilead Sciences, Inc.
- Address:
- 333 Lakeside Drive, Foster City, CA 94404, United States (US)
Inventor
- Name:
- LARSON, Nate
- Address:
- United States (US)
Priority
- Priority Number:
- 201762530971 P
- Priority Date:
- 11/07/2017
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 9/00; A61K 9/19; A61K 31/683; A61K 47/40; A61P 31/12;
Publication
European Patent Bulletin
1
- Issue number:
- 202446
- Publication date:
- 13/11/2024
- Description:
- Grant (B1)
2
- Issue number:
- 202504
- Publication date:
- 22/01/2025
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202504
- Publication date:
- 22/01/2025
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|